June 25, 2019
CNT expands into Benelux region
Company takeover and opening of Hasselt office in Belgium HASSELT, Belgium–(BUSINESS WIRE)–CNT Management Consulting, a leading SAP consultancy in Austria…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
June 25, 2019
Keytruda’s diffuse large Bcell lymphoma market potential remains limited
Keytruda’s market potential in this indication remains limited due to its approval for primary mediastinal B-cell lymphoma (PMBCL), which only accounts for a small percentage of non-Hodgkin’s lymphoma (NHL) patients.
June 25, 2019
Tilray Imports Bulk Supply of Medical Cannabis Oil into the United Kingdom
Tilray has imported medical cannabis oral solutions in bulk into the United Kingdom from its Good Manufacturing Practices (GMP)-certified facility in Canada.
June 25, 2019
Almirall Exercises its Option with Dermira to License Rights to Lebrikizumab in Europe for Atopic Dermatitis
Dermira set to receive an option exercise fee of $50 million and additional potential milestone payments and royalties
June 25, 2019
Longboat Clinical Launch Patient CONNECT to Streamline Patient Recruitment Process
Longboat Clinical, the clinical technology company specializing in site and patient engagement platforms, today announced the release of Patient CONNECT, a unique solution to streamline patient recruitment into clinical trials and provide much sought-after insights to drug development teams.
June 25, 2019
Patient Engagement in R&D: Still a Challenge for Pharma Companies
DUBLIN–(BUSINESS WIRE)–The “Patient Engagement in R&D: Still a Challenge” report has been added to ResearchAndMarkets.com’s offering. The pharmaceutical industry has…
June 25, 2019
The Global Biopharmaceuticals Market is Projected to Grow by 8.7% Through to 2025 and Reach $446 Billion
DUBLIN–(BUSINESS WIRE)–The “Biopharmaceuticals – A Global Market Overview” report has been added to ResearchAndMarkets.com’s offering. The biopharmaceuticals market is driven…
June 24, 2019
Bioasis Announces Allowances of Patent Applications in the U.S. and Europe Relating to xB3 Platform Technology and Key Therapeutic Indications
U.S. Patent Office and European Patent Office issue allowances of patent applications relating to iduronate-2-sulfatase (“IDS”) polypeptide/xB3 conjugates European Patent…
June 24, 2019
Cryptosporidiosis: Global Clinical Trials Review (H1, 2019)
DUBLIN–(BUSINESS WIRE)–The “Cryptosporidiosis Global Clinical Trials Review, H1, 2019” clinical trials has been added to ResearchAndMarkets.com’s offering. Cryptosporidiosis Global Clinical…
June 24, 2019
Migraine Market Spotlight: Global Analysis& Outlook
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Migraine” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Migraine market,…